Connect with us
Since May 26th Mr Bear has been a very bad bear. We’ve seen three NYSE days of extreme market breadth in the past month. During bull...
If you’re not maintaining consistency in your branding, things can quickly go awry, creating devastating consequences for you and your business. Even many legendary, well-established brands...
Solarisbank's big goal was actually always IPO. An exit to a private equity investor was not on the roadmap. However, the IPO is not likely to...
To become the preferential choice for companies interested in business expansion and set themselves up for a robust post-pandemic recovery, every community must consider these four...
When has the market experienced this large of a drop within one year in recent memory? It has happened six other times since 1980. Here are the rough...
Horyuji Temple is the first in Japan to be designated a World Heritage Site and will celebrate the 30th anniversary of the designation next year. However,...
Ecopetrol's shares fell 11.92% on the BVC, reaching $2,431; and its ADR on the New York Stock Exchange (Nyse) fell 11%, while its international peers, such...
PBEs have doubled the number of clinical trials in the last five years, and their success rates are higher than those of their 'big sisters', according...
The World Bank organized this Tuesday, June 21st, 2022, a joint review of the performance of the portfolio of projects and programs it has financed in...
Satellos Bioscience is developing stem cell signaling pharmaceuticals that could reshape the way we treat muscular dystrophies like Duchenne muscular dystrophy (DMD). Its work is based...
 |
|
 |  |
 |
|